Stem cell therapy describes the process of introducing stem cells into tissue to treat a disease with or without the addition of gene therapy. Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury and immune disorders. Additionally, MSCs have been implicated in the promotion of tumor growth in numerous cancer types. BioCytoceuticals is a leading company working on high-quality bioprocessing in MSC production to meet customers' requirements.
Phenotypic and functional characterization of MSCs. (A) The morphology of umbilical cord-derived MSC and their differentiation into adipogenic, chondrogenic, and osteogenic lineages. (B) Immunophenotypic characterization of UC-MSC by Flow Cytometry.
BioCytoceuticals is an experienced and outstanding provider of MSC production service. We are dedicated to providing detailed data and comprehensive service for your scientific research, and we are pleased to use our extensive experience and advanced platform to offer the best service to satisfy each demand from our customers.
If You Have Any Question About Our Service, Please Let Us Know.
Do not hesitate to contact us for this special service. Please let us know what you need and we will accommodate you. We are looking forward to working with you in the future.
Inquiry
